Hypercholesterolemia
840
23
35
674
Key Insights
Highlights
Success Rate
94% trial completion (above average)
Published Results
199 trials with published results (24%)
Research Maturity
674 completed trials (80% of total)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 30/100
5.1%
43 terminated out of 840 trials
94.0%
+7.5% vs benchmark
37%
307 trials in Phase 3/4
30%
199 of 674 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 674 completed trials
Clinical Trials (840)
Alleviation of Hypercholesterolemia Through Newly Developed Cookies Supplementedwithpumpkin (Cucurbita Pepo L.) Seeds and Walnuts (Juglans Regia L.) Among Arthrosclerosispatients.
RCT for the Chinese Medicine in Treating Hypercholesterolemia
A Study to Investigate LDL-cholesterol Lowering With Inclisiran Compared to Bempedoic Acid in Patients With Atherosclerotic Cardiovascular Disease.
A Study of Bempedoic Acid/Ezetimibe/High-intensity Statin in Patients Without Cardiovascular Events
A Study to See How Safe and Effective Alirocumab is When Given Weekly to Adult Participants Who Have Hypercholesterolemia
Phase 1b Study of VERVE-201 in Patients With Refractory Hyperlipidemia
A Clinical Study in Children With Heterozygous Familial Hypercholesterolemia (HeFH) Aged 6 to 17 Treated Once Daily With Bempedoic Acid Oral Dosing (CLEAR Path 1)
Causes and Natural History of Dyslipidemias
A Post-Marketing Clinical Trial of Pemafibrate in Patients ｗith Hypercholesterolemia and Inadequate Response to Statins
To Evaluate the Safety and Pharmacokinetic Characteristics of AJU-C716 and C716R in Healthy Adults
Assessing Outcomes of Enhanced Chronic Disease Care Through Patient Education and a Value-based Formulary Study
Effects of a Digital Health Application (Lipodia) on LDL-cholesterol Levels
A Phase 3 Clinical Trial to Evaluate the Efficacy and Safety of AG2304T and AG2304R
Moderate-Intensity Statin Plus Ezetimibe in CKD and ASCVD
A Study Of SHR-1918 In Participants With Hypercholesterolemia With Inadequate Lipid Control on Statins Plus PCSK9 Inhibitors
Pharmacokinetics of Butyrate Tablet BKR-017
Dual PCSK9 Inhibition With Inclisiran and Alirocumab in Secondary Prevention
Pravastatin and Protease Inhibitors in HIV-infected Patients
Church-based Health Intervention to Eliminate Racial Inequalities in Cardiovascular Health
Lipoprotein Metabolism in Normal Volunteers and Patients With High Levels of Lipoproteins